When 5-HT binds to liver 5-HTR, it lowers the levels of tumor necrosis factor-α (TNF-α) and NF-κB, modulating hepatic macrophage immunity, inhibiting inflammation, and protecting the liver from multiple insults, making this an important MASLD prevention mechanism [96,97]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.